Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 3,105.00
+40.00 (1.31%)
At close: Sep 29, 2025
Seoul Pharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -660.9 | 1,699 | 3,517 | 855.09 | -9,689 | -1,342 | Upgrade |
Depreciation & Amortization | 2,651 | 2,490 | 1,928 | 2,613 | 2,528 | 2,443 | Upgrade |
Loss (Gain) From Sale of Assets | 20.1 | 0.05 | 8.26 | 0.02 | 0.01 | 0.51 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 2,177 | 198.8 | 4,369 | Upgrade |
Loss (Gain) From Sale of Investments | -91.94 | -67.49 | -63.71 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | 0.75 | -14.53 | -6.14 | -9.64 | 24.12 | -39.11 | Upgrade |
Other Operating Activities | 1,989 | 1,549 | 2,270 | -207.94 | 4,898 | 797.69 | Upgrade |
Change in Accounts Receivable | -2,114 | -4,071 | -111.42 | -381.62 | -1,261 | 4,685 | Upgrade |
Change in Inventory | -945.39 | -1,623 | -1,920 | -2,769 | 270.5 | 2,111 | Upgrade |
Change in Accounts Payable | -819.21 | -410.48 | -164.12 | 1,020 | 1,173 | -1,550 | Upgrade |
Change in Unearned Revenue | - | - | - | - | - | -0.13 | Upgrade |
Change in Other Net Operating Assets | -2,843 | -2,559 | -193.42 | -3,375 | 181.78 | -5,739 | Upgrade |
Operating Cash Flow | -2,981 | -3,008 | 5,265 | -78.21 | -1,675 | 5,737 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | 91.95% | Upgrade |
Capital Expenditures | -1,324 | -2,229 | -1,893 | -1,233 | -1,157 | -452.02 | Upgrade |
Sale (Purchase) of Intangibles | -1.75 | -0.7 | -1.52 | -66.23 | -10.71 | -219.22 | Upgrade |
Investment in Securities | 3,146 | 3,146 | -4,023 | - | 3.18 | 355.09 | Upgrade |
Other Investing Activities | 1,013 | 540.74 | 55 | -33 | 1 | -1 | Upgrade |
Investing Cash Flow | 2,833 | 1,457 | -5,862 | -1,332 | -1,099 | -293.15 | Upgrade |
Short-Term Debt Issued | - | 3,000 | - | 4,000 | 4,000 | - | Upgrade |
Long-Term Debt Issued | - | 10,000 | - | - | 10,000 | 15,000 | Upgrade |
Total Debt Issued | 5,000 | 13,000 | - | 4,000 | 14,000 | 15,000 | Upgrade |
Short-Term Debt Repaid | - | - | -4,000 | -4,000 | -2,000 | -2,000 | Upgrade |
Long-Term Debt Repaid | - | -10,620 | -465.7 | -474.25 | -10,465 | -10,867 | Upgrade |
Total Debt Repaid | -767.01 | -10,620 | -4,466 | -4,474 | -12,465 | -12,867 | Upgrade |
Net Debt Issued (Repaid) | 4,233 | 2,380 | -4,466 | -474.25 | 1,535 | 2,133 | Upgrade |
Dividends Paid | - | - | - | - | - | -127.28 | Upgrade |
Other Financing Activities | -0 | -0 | - | -8.94 | -0 | -0.72 | Upgrade |
Financing Cash Flow | 4,233 | 2,380 | -4,466 | -483.19 | 1,535 | 2,005 | Upgrade |
Foreign Exchange Rate Adjustments | -74.46 | 138.15 | -91.7 | -198.35 | 1.74 | -56.27 | Upgrade |
Net Cash Flow | 4,011 | 966.43 | -5,155 | -2,092 | -1,237 | 7,392 | Upgrade |
Free Cash Flow | -4,305 | -5,237 | 3,372 | -1,311 | -2,831 | 5,285 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 84.79% | Upgrade |
Free Cash Flow Margin | -8.25% | -9.78% | 6.43% | -2.62% | -7.00% | 10.12% | Upgrade |
Free Cash Flow Per Share | -369.24 | -449.20 | 289.20 | -146.00 | -332.16 | 621.86 | Upgrade |
Cash Interest Paid | 499.5 | 427.49 | 442.51 | 491.88 | 457.9 | 591.16 | Upgrade |
Cash Income Tax Paid | 25.06 | 11.53 | 4.36 | 31.28 | 165.54 | 943.38 | Upgrade |
Levered Free Cash Flow | -4,213 | -7,405 | -524.76 | -2,459 | 1,277 | 5,702 | Upgrade |
Unlevered Free Cash Flow | -3,937 | -7,129 | -248.19 | -1,757 | 1,984 | 6,476 | Upgrade |
Change in Working Capital | -6,888 | -8,663 | -2,389 | -5,506 | 364.94 | -493 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.